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Abstract
Background: The role of the receptor for advanced glycation end-products (RAGE) has been shown to differ in two different
mouse models of asbestos and bleomycin induced pulmonary fibrosis. RAGE knockout (KO) mice get worse fibrosis when
challenged with asbestos, whereas in the bleomycin model they are largely protected against fibrosis. In the current study
the role of RAGE in a mouse model of silica induced pulmonary fibrosis was investigated.
Methodology/Principal Findings: Wild type (WT) and RAGE KO mice received a single intratracheal (i.t.) instillation of silica
in saline or saline alone as vehicle control. Fourteen days after treatment mice were subjected to a lung mechanistic study
and the lungs were lavaged and inflammatory cells, protein and TGF-b levels in lavage fluid determined. Lungs were
subsequently either fixed for histology or excised for biochemical assessment of fibrosis and determination of RAGE protein-
and mRNA levels. There was no difference in the inflammatory response or degree of fibrosis (hydroxyproline levels) in the
lungs between WT and RAGE KO mice after silica injury. However, histologically the fibrotic lesions in the RAGE KO mice had
a more diffuse alveolar septal fibrosis compared to the nodular fibrosis in WT mice. Furthermore, RAGE KO mice had a
significantly higher histologic score, a measure of affected areas of the lung, compared to WT silica treated mice. A lung
mechanistic study revealed a significant decrease in lung function after silica compared to control, but no difference
between WT and RAGE KO. While a dose response study showed similar degrees of fibrosis after silica treatment in the two
strains, the RAGE KO mice had some differences in the inflammatory response compared to WT mice.
Conclusions/Significance: Aside from the difference in the fibrotic pattern, these studies showed no indicators of RAGE
having an effect on the severity of pulmonary fibrosis following silica injury.
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Introduction
Pulmonary fibrosis can have various causes and can be a
debilitating progressive condition with a poor prognosis. Fibrosis
can develop as a response to inhaled fibrogenic fibers or particles,
such as asbestos fibers or silica particles [1,2]. It can also develop
as a side effect of treatment with chemotherapeutic agents or be
idiopathic (IPF) with no identifiable etiology [3,4]. Although
silicosis is 100% preventable by proper personal protection, it is
still a widespread disease. In the United States the annual number
of deaths with silicosis as the underlying or contributing cause has
decreased from over 1,100 back in 1968 to under 200 in 2004 [5].
In contrast, China recorded 500,000 cases of silicosis in the period
1991–1995 with an incidence of around 6,000 per year with more
than 24,000 deaths annually [6].
A number of murine models are utilized to study IPF and other
human forms of pulmonary fibrosis in order to investigate disease
progression and potential therapy. Among these models are
bleomycin, fiber/particle (asbestos, silica), irradiation, fluorescein
isothiocyanate, and transgenic mice strains with pulmonary
specific transgenes or virus targeted transgene delivery (Reviewed
in [7]).
Inhaled fibers and particles such as asbestos and silica are not
effectively cleared from the lung by macrophages and instead lead
to chronic inflammation and fibrosis. This is different from the
bleomycin model which initiates an acute single injury followed by
fibrosis and then resolution [8,9]. Silica in the lung is first
encountered by alveolar macrophages, where the membrane
spanning scavenger receptor MAcrophage Receptor with COl-
lagenous structure (MARCO) is the receptor primarily responsible
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9604for recognition and internalization of silica [10]. Not only does the
uptake of silica by macrophages lead to an inflammatory response
by activation of the napl3 inflammasome [11], it also causes a dose
dependent cytotoxicity which leads to further inflammation
culminating in pulmonary fibrosis [10].
The receptor for advanced glycation end-products (RAGE) is a
member of the super family of immunoglobulin receptor molecules
and exists both as a membrane bound and a soluble form lacking
the trans-membrane domain [12]. Among its ligands are advanced
glycation end-products (AGEs) [13], high mobility group box
protein 1 (HMGB1) [14], S100 [15] and amyloid b-peptides [16].
RAGE has in recent years been implicated in a number of diseases
including diabetic vascular disease and renal fibrosis [17–19]. In
contrast to most tissues/organs where RAGE expression is
Figure 1. RAGE protein and mRNA levels are decreased after silica injury. (A) Western blot of total protein in lung homogenate of lungs
from control and silica treated WT mice, 5 mg of protein were loaded per lane. In addition to mRAGE and sRAGE a third isoform of RAGE, recently
termed xRAGE [40], was also detected by western blot. (B) Protein levels of total RAGE normalized to b-actin revealed a significant decrease in
expression after silica injury. (C–E) When split into the different isoforms only mRAGE showed a significant decrease in protein, while both xRAGE and
sRAGE had a trend towards a decrease. (F–G) RAGE mRNA levels were significantly decreased after silica injury supporting the observation of the
protein levels. This was significant when normalizing to both of the endogenous controls GAPDH and b-actin. Mann Whitney test (n=4–5 per group).
*p ,0.05 silica vs. control.
doi:10.1371/journal.pone.0009604.g001
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high amounts in the normal lung and is significantly depleted in
response to injuries leading to pulmonary fibrosis [20,21]. The role
of RAGE in pulmonary fibrosis is not fully understood. Recent
studies have found that RAGE KO mice spontaneously get
pulmonary fibrosis as they age and also get worse fibrosis than WT
mice in response to asbestos injury [21]. In contrast, RAGE KO
mice are largely protected against fibrosis in a bleomycin model
[22]. The bleomycin study suggested that RAGE contributes to
bleomycin-induced lung fibrosis through epithelial-mesenchymal
transition (EMT) and profibrotic cytokine production, and they
found that RAGE KO mice had reduced BALF levels of the
profibrotic cytokines transforming growth factor-b (TGF-b) and
platelet-derived growth factor (PDGF) which are both RAGE
inducible. Furthermore, they found that while WT primary
alveolar type II epithelial cells were able to undergo EMT when
stimulated with HMGB1, cells from RAGE KO mice were not,
suggesting that RAGE may be involved in EMT.
In this paper data is presented from an investigation of the role
of RAGE in a third model using silica to induce pulmonary
fibrosis.
Materials and Methods
Ethics Statement
All animal experiments were reviewed and approved by the
Institutional Animal Care and Use Committee at the University of
Pittsburgh. Animals were given free access to food and water and
were cared for according to guidelines set by the American
Association for Laboratory Animal Care.
Mouse Treatments
The RAGE KO strain was generated on a C57BL/6
background [23]. WT mice were purchased from Taconic
(Germantown, NY).
Eight to 10 week old mice were anesthetized with Isoflurane
(Baxter Healthcare Corporation, IL) and then received a single
70 mL i.t. instillation of either silica solution (0.2, 1, or 5 mg/
mouse) or 0.9% saline as a vehicle control. Prior to instillation the
5 mm silica particles (a gift from Andy Ghio, Environmental
Protection Agency) were baked at 180uC for 6 hrs. Mice were
weighed every day to monitor weight loss/gain. Male mice were
used for all experiments except for the dose response study.
Determination of Respiratory Mechanics
Fourteen days after injury animals were anesthetized with
60 mg/kg pentobarbital sodium intraperitoneally (Ovation Phar-
maceuticals Inc., Deerfield, IL), a tracheostomy was performed,
and they were attached to a ventilator. Following 5 minutes of
stabilization, every animal received deep lung inflation to 30 cm
H2O distending pressure to ensure uniform lung recruitment, and
normalization to the same pre-assessment volume history.
Readings were obtained at a positive end-expiration pressure of
0c mH 2O in triplicate. After 2 minutes, a second set of baseline
recordings were obtained without preceding deep lung inflation.
Physiological recordings were performed using a computer-
controlled ventilator (flexiVent, Scientific Respiratory Equipment
Inc, QC, Canada). Mice were ventilated with a tidal volume of
10 mL/kg at a respiratory rate of 200 breaths/min. Lung
mechanics were measured at specific intervals by triggering the
ventilator to deliver a custom input flow wave specifically
developed to characterize murine lung impedance (i.e. the ratio
of pressure to flow) over the physiological range of breathing
frequencies (20 to 200 breaths/min).
Inflammatory Cells
Fourteen, 21 or 28 days after treatment mice were sacrificed by
an overdose of sodium pentobarbital (Ovation Pharmaceuticals
Inc.) and the lungs were lavaged with a single instillation of 800 mL
normal saline. Recovery of bronchoalveolar lavage fluid (BALF)
was consistently above 75%. BALF cells were counted using a Z1
Coulter Particle Counter (Beckman Coulter Inc., Fullerton, CA)
and 30,000 cells were transferred to glass slides using a Shandon
Cytospin 4 (Thermo Electron Corporation, Pittsburgh, PA) at
750 rpm for 5 min. After 2 days of drying, cells were stained using
the Diff-Quick stain (Dade Behring Inc., DE), and macrophages,
neutrophils and lymphocytes were counted (200 cells).
Figure 2. Hydroxyproline levels in WT and RAGE KO lungs were significantly higher in silica treated (closed bars) compared to
saline controls (open bars). There were no significant differences between WT and RAGE KO hydroxyproline levels in the silica injured mice after
both 14- and 21 days. Data were analyzed using 2-way ANOVA with a Bonferroni post-test and are means (6SEM) (n=5–6 per group). * p,0.05 silica
vs. control.
doi:10.1371/journal.pone.0009604.g002
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Protein concentration in undiluted BALF was measured by a
standard endpoint measurement at 495 nm using Bradford
reagent with a bovine serum albumin standard curve (Thermo
Scientific, Rockford, IL).
Hydroxyproline Assay
Collagen deposition was measured by hydroxyproline assay as
previously described [24]. Briefly, dried lungs were acid hydrolyzed
in 6 N HCl at 110uC under nitrogen gas. After evaporation of HCl,
samples were resuspended in PBS and incubated in a 60uC water
bath. Following three consecutive high speed centrifugations a 40x
dilution in PBS of the supernatant was oxidized with chloramine-T
and the reaction was stopped with perchloric acid. Finally, p-
dimethylaminobenzaldehydewasadded andsampleswere analyzed
spectrophotometrically at 557 nm. Hydroxyproline content per
lung was calculated from a hydroxyproline standard curve.
Histology and Histologic Scoring
Lungs used for histology were inflation fixed with 800 mL 10%
formalin for 8 min and paraffin embedded. Five mm sections were
H&E stained and fibrosis was evaluated under 4006magnification
by a pathologist, blinded to the nature of the mice, scoring each
field of the entire lung section according to the following criteria;
0: no fibrosis, 1: 0 to 25%, 2: 25 to 50%, 3: 50 to 75% and 4: 75 to
100%, as previously described [21,25].
Lung Homogenate and Quantitative Real-Time PCR (qRT-
PCR) Analysis
Lungs were perfused with 10 mL normal saline, excised and
flash frozen in liquid nitrogen before being stored at 280uC until
use. Each lung was used to get both protein and mRNA by
pulverizing in liquid nitrogen as described elsewhere [26]. mRNA
was extracted from 100 mg of lung powder using the RNeasy Mini
Kit (Qiagen, Valencia, CA) to obtain RNA with an A260/
A280 $1.9. One mg RNA was reverse transcriped to cDNA and
real time PCR was performed on a 7300 Real-Time PCR System
(Applied Biosystems, Foster City, CA) as previously described (25)
using mouse GAPDH (Mm99999915_g1) and mouse b-actin
(Mm00607939_s1) as endogenous controls and the RAGE probe
(Mm00545815_m1) as the target gene (Applied Biosystems).
Relative quantity was calculated based on the DDCt method (26).
Total protein was extracted from the rest of the lung powder in
CHAPS buffer as previously described [27]. Protein concentration
was measured as described above for BALF and 5 mg of total protein
was separated by SDS-PAGEas described below for western blotting.
Western Blotting
SDS-PAGE was performed with 5–15% gradient gels using the
glycine/2-amino-2-methyl-1,3-propanediol/HCl system as previ-
ously described [28]. Proteins were transferred onto a PVDF
membrane (Millipore, Bedford, MA) and the membrane was
blocked in 5% milk in PBS-T.
The membrane was incubated with a 1:5,000 dilution of
primary antibody against RAGE generated as previously de-
scribed [29] or a 1:1,000 dilution of rabbit-anti HMGB1 (Abcam,
Cambridge, MA). After washing, the membrane was incubated
with a HRP-conjugated donkey-anti-rabbit antibody (GE Health-
care, Buckinghamshire, UK). The membrane was developed and
visualized using the enhanced chemiluminescent plus reagent (GE
Healthcare) and a KODAK GelLogic 2200 Imaging system
(Carestream Health, Rochester, NY). Loading control was
performed by normalizing band intensity to b-actin (Sigma-
Aldrich, St. Louis, MO). For protein loading control of BALF
samples PVDF membranes were stained with ponceau S stain.
ELISA for TGF-b Concentration in BALF
Active and total TGF-b in BALF was measured in undiluted
BALF using the mouse TGF-b Duoset ELISA Development kit
(R&D systems Inc., Minneapolis, MN) according to manufactures
instructions for cell media.
Statistical Analysis
Data were analyzed using GraphPad Prism 5.0 (GraphPad
Software Inc., La Jolla, CA). Experiments involving both WT and
RAGE KO (4 groups) were analyzed by two-way analysis of
variance with a Bonferroni post-test. Data with one variable were
analyzed by a Mann Whitney test. All values are means (6SEM).
*p ,0.05 was considered significant.
Results
RAGE Protein and RAGE mRNA Are Down Regulated in
Lungs with Silicosis
Membrane RAGE is highly expressed on epithelial type I cells
in the lung and consequently has been suggested to be a marker of
loss of epithelial type I cells [30]. During inflammation and
development of fibrotic areas in the lung, type I epithelial cells are
injured and lost which should lead to decreased levels of
membrane RAGE in the lung. RAGE protein levels in total lung
homogenate 14 days after silica challenge was investigated
(Figure 1A–E). Consistent with the above hypothesis, a significant
decrease of total RAGE was observed. In addition, while the
individual isoforms xRAGE and sRAGE only trended towards a
decrease, mRAGE decreased significantly after silica injury.
Furthermore, RAGE mRNA levels were significantly decreased
in silica injured lungs (Figure 1F–G), which is consistent with the
decrease in protein levels.
Hydroxyproline Levels in the Lungs after Injury
Only a few macromolecules such as the scleroproteins collagen
and elastin contain hydroxyproline in significant amounts, with
collagen the most abundant source [24]. Thus, hydroxyproline
levels directly correlate with levels of collagen deposition in the
lung tissue and is used as a measure of fibrosis after silica injury.
While hydroxyproline levels in the lungs of silica treated WT and
Figure 3. RAGE KO mice have a different fibrotic pattern than WT mice. Lungs were fixed in 10% formalin and paraffin embedded. After H&E
staining the lungs were inspected by microscopy (A) and scored according to the degree of fibrosis in each high power field (B and C). When
comparing the silica treated WT and RAGE KO lung sections, it is evident that there is a marked difference in the fibrotic pattern among the two
strains at both the 14-, 21-, and to a lesser extend the 28 day time point. WT mice have characteristic nodular shaped fibrotic regions, whereas RAGE
KO mice develop less dense nodules with a more diffuse alveolar septal fibrosis. Silica treatment resulted in a significant increase in the histologic
score for both WT and RAGE KO at the 14- and 28 day time points, and RAGE KO mice had a significantly higher score than WT mice after 14 days (B).
After 28 days there was a trend towards what was seen after 14 days (C). Both WT and RAGE KO control treated mice had no fibrosis and therefore a
score of 0 throughout (Data not shown). Data are means (6SEM) analyzed by 2-way ANOVA with a Bonferroni post-test. Black scale bars represent
500 mm. (n=5–6 per group for 14 day time point and n=3 per group for 28 day time point). * p,0.05 RAGE KO vs. WT.
doi:10.1371/journal.pone.0009604.g003
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treated lungs 14- and 21 days after silica challenge, there were no
significant differences between the two strains (Figure 2).
RAGE KO Mice Display a Different Histologic Pattern of
Fibrosis Compared to WT Mice
H&E staining of lungs 14-, 21-, and 28 days post treatment
revealed a different histologic pattern of fibrosis among the two
mouse strains (Figure 3A). While the WT mice developed
characteristic nodular shaped fibrotic areas associated with silica
induced fibrosis, the RAGE KO mice developed nodular lesions
with a more diffuse fibrosis which extends from the nodules into
the alveolar septa. In addition, histologic scoring revealed a
significantly higher degree of affected area in the silica treated
RAGE KO mice compared to WT mice after 14 days (Figure 3B),
but not after 28 days (Figure 3C). This may suggest that absence of
RAGE delays the coalescence of the fibrotic nodules.
Analysis of White Blood Cells and Protein in BALF
Total cells/mL in the BALF was significantly increased 14- and
21 days after silica challenge for both WT and RAGE KO mice
(Figure 4A and 5A). However, there were no differences between
the two strains. Analysis of leukocytes in the BALF showed that in
both WT and RAGE KO control treated mice the main cell type
found was the macrophage with a very small amount of neutrophils
and lymphocytes (Figure 4B–D and 5B–D). Fourteen days after
silica treatment there was an increase in neutrophils compared to
control treatment for both WT and RAGE KO. Lymphocytes on
the other hand were only significantly up regulated in RAGE KO
miceaftersilica injury.Furthermore,therewas a significantlyhigher
increase in neutrophils in the WT compared to RAGE KO. In
contrast, RAGE KO mice had significantly more lymphocytes after
injury than WT mice. Twenty one days after silica treatment there
was no longer a significant difference in the neutrophil population
between control and silica treated mice (Figure 5C), and only the
RAGE KO mice had a significant increase in lymphocytes
compared to control (Figure 5D).
Protein concentration in the BALF was used as another measure
of lung injury. Injury to the lung parenchyma and loss of epithelial
cells leads to leakage from the vasculature of proteinaceous fluid
into the lung. RAGE KO mice had significantly higher protein
concentration in the BALF 14 days after silica injury compared to
WT silica treated mice (Figure 4E), but 21 days after injury there
was only a trend towards more protein in the BALF of the RAGE
KO mice (Figure 5E).
Effect of Knock Out of RAGE on Total TGF-b
Concentration in BALF
TGF-b is an important growth factor involved in the
development of pulmonary fibrosis (Reviewed in [31,32]). The
level of total TGF-b in the BALF of both control and silica treated
WT and RAGE KO mice 14 days after treatment was assayed by
ELISA (Figure 4F). Silica treated RAGE KO mice had a
significantly lower concentration of TGF-b in the BALF compared
to silica treated WT mice. This is consistent with a previously
report that TGF-b levels were lower in BALF from bleomycin
treated RAGE KO compared to WT mice [22].
Western Blot of Bronchoalveolar Lavage Fluid for Soluble
RAGE and HMGB1
BALF samples were assayed by western blot for soluble RAGE
and the inflammatory cytokine HMGB1 14 days after silica
challenge (Figure 6). Soluble RAGE levels have previously been
shown to increase in the BALF in a model of acute lung injury
[33]. Furthermore, HMGB1 has been shown to be able to induce
EMT in vitro [22], hence increased levels of HMGB1 could
potentially drive EMT and fibrosis. Soluble RAGE in the BALF
was slightly increased in WT BALF after silica challenge
(Figure 6A). The level of HMGB1 after silica treatment in both
the WT and RAGE KO mice was also increased (Figure 6A–B).
From the western blot the level appears to be the same, but equal
amount of protein was loaded in each lane and since the silica
treated mice had higher protein concentration in the BALF
(Figure 4), an equal intensity actually indicates a higher level of
HMGB1 on a per volume basis. Furthermore, there were no
significant differences in the level of HMGB1 between WT and
RAGE KO silica treated mice (Figure 6C).
Lung Mechanistic Study
Fibrotic areas in the lung lead to decreased pulmonary function
because the collagen deposition leads to a restriction in flexibility
of the normally very elastic structure of the lung. By the use of
delicate equipment such as the flexiVent system it is possible to
collect information on the functional state of small lungs such as
those from mice [34].
Airway and tissue resistance, -compliance and -elastance were
measured (Figure 7). We hypothesized that the more diffuse
development of fibrosis in RAGE KO mice would lead to a more
impaired pulmonary function than the WT mice. While silica
treated WT and RAGE KO mice had a significant decrease in
pulmonary function as measured by airway resistance, -compli-
ance, and -elastance, and tissue resistance and -elastance, over the
saline treated controls, there was no statistical significant difference
between WT and RAGE KO mice. Airway resistance was only
significantly increased in RAGE KO silica mice compared to
control, and not in WT silica vs. control mice (Figure 7A).
Dose Response in Female Mice
In order to verify that the above observations were consistent
using different amounts of silica, a dose response was carried out in
female mice and sacrificed 21 days after silica challenge. Doses of
0.2 mg, 1 mg and 5 mg silica per mouse were used. Analysis of
BALF cells, protein concentration in BALF and hydroxyproline
Figure 4. Analysis of BALF specimens 14 days after treatment. Lungs were lavaged with 800 mL saline and cells were counted in triplicate.
Thirty thousand cells were transferred to a glass slide using a cytospin and stained. Two hundred cells were counted to determine the percentage of
macrophages, lymphocytes and neutrophils. (A) Both silica treated WT and RAGE KO (closed bars) had significantly more total cells per mL in the BALF
compared to control treated mice (open bars). There was not a significant difference between WT and RAGE KO mice. However, while there was no
difference in number of macrophages (B), RAGE KO mice had significantly less neutrophils but more lymphocytes than WT mice treated with silica (C–
D). (E) Protein concentration in the BALF was used as a measure of lung permeability and hence lung injury. There was a significant increase in
protein concentration in silica treated BALF from both WT and RAGE KO over the controls. In addition, silica treated RAGE KO mice had significantly
higher protein concentration in the BALF compared to WT mice. (F) Total TGF-b level in BALF was significantly lower in RAGE KO compared to WT
silica treated mice. No active TGF-b was detected in BALF samples. Data are means (6SEM) analyzed by 2-way ANOVA with a Bonferroni post-test.
Asterisks above error bars represent comparison to the control treated of the same strain. Asterisks above line represent an interaction and hence a
difference between WT and RAGE KO mice. (n=7–9 per group). * p,0.05 silica vs. control, ** p,0.05 WT vs. RAGE KO.
doi:10.1371/journal.pone.0009604.g004
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PLoS ONE | www.plosone.org 7 March 2010 | Volume 5 | Issue 3 | e9604Figure 5. Analysis of BALF specimens 21 days after treatment. (A) Both silica treated WT and RAGE KO (closed bars) had significantly more
total cells per mL in the BALF compared to control treated mice (open bars). There was not a significant difference between WT and RAGE KO mice.
Furthermore, the number of macrophages in both WT and RAGE KO BALF was not significantly increased over control treated mice (B). While the level
of neutrophils increased significantly with silica treatment compared to controls for both strains (C), only RAGE KO mice had a significant increase in
lymphocytes after silica treatment (D). (E) Protein concentration in the BALF also increased significantly with treatment, but there was no difference
between the two strains. Data are means (6SEM) analyzed by 2-way ANOVA with a Bonferroni post-test. (n=6–7 per group). * p,0.05 silica vs.
control.
doi:10.1371/journal.pone.0009604.g005
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Only the high dose of silica led to a significant higher level of cells
in the BALF from RAGE KO mice compared to WT mice
(Figure 8A), which were mainly macrophages (Figure 8B). In
addition, RAGE KO mice had less neutrophils with silica
treatment compared to wild type mice for all doses of silica
(Figure 8C) and slightly different lymphocyte infiltration at the low
and medium dose of silica (Figure 8D). Furthermore, protein
concentration in the BALF was significantly higher in the RAGE
KO mice at all doses of silica compared to WT mice (Figure 8E).
However, there were no differences in hydroxyproline levels
between the two strains at any of the 3 different doses of silica
(Figure 8F). H&E staining of fixed lung sections from the different
doses showed no signs of fibrosis at the low dose, very mild
changes in the medium dose, and a similar extent and pattern of
fibrosis as indicated in figure 3 for the high dose of 5 mg silica per
mouse (Data not illustrated).
Discussion
The role of RAGE has previously been studied in an asbestos
and a bleomycin model of pulmonary fibrosis [21,22]. Notably,
the absence of RAGE was found to lead to spontaneous fibrosis
with aging and increased fibrosis in response to asbestos injury
[21]. In contrast, RAGE KO mice were found to be largely
protected against bleomycin induced fibrosis [22]. Here, the role
of RAGE in a silica model of pulmonary fibrosis was studied.
Injury led to a decrease in RAGE mRNA levels and a decrease in
total RAGE protein in total lung homogenates. This is consistent
with findings in both the bleomycin model and asbestos model as
well as in lungs from human IPF patients [20–22]. The decrease in
membrane RAGE protein is likely to be a direct effect of loss of
type I epithelial cells and may also be due to cleavage of
membrane RAGE by proteases to form soluble RAGE [35,36].
The loss of soluble RAGE is more likely to be an indicator of tissue
damage and damage to the extracellular matrix, but may be due to
decreased production from injured epithelial cells. Previous studies
have shown that shedding of syndecan-1, a heparin sulfate
proteoglycan highly abundant in the extracellular matrix, occurs
in models of pulmonary fibrosis [37]. Since soluble RAGE has
high affinity to heparin sulfate, collagen and other extracellular
matrix proteins [29,36,38], it is likely that damage to those
structures will result in release of bound soluble RAGE. In fact,
soluble RAGE has been shown to accumulate in the BALF after
acute lung injury [33]. However, barely any soluble RAGE was
detected in the BALF of WT mice both before and after silica
injury. This may be due to clearance of soluble RAGE from the
BALF after the initial injury.
The silica model of pulmonary fibrosis is more closely related to
the asbestos model than the bleomycin model, in that the silica
particles are relatively resistant to clearance from the lung and lead
to inflammation and fibrosis around the silica particles. This is
visualized by the characteristic silicotic nodules (Figure 3, wild type
Figure 6. Western blot of BALF specimens for soluble RAGE
and HMGB1. Equal amounts of protein were loaded in each lane of
the individual gels to assure maximum loading of protein. Protein
amounts were limited to the maximum amount of protein that could be
loaded from the most dilute sample. Protein amounts were as follows;
A, 4.4 mg; B, 6.9 mg; C, 11.2 mg. Lower panel in each section shows a
section of the ponceau S stained membrane, to assure equal loading of
protein. Comparison between blots is not the intension of these
western blots. Densitometry analysis was performed on the soluble
RAGE and HMGB1 bands, and different treatments compared within
each gel by a Mann Whitney test (Data not shown). (A) Compares the
two proteins without and with silica treatment in WT mice. Some very
weak soluble RAGE bands are visible both in control and silica treated
WT BALF. HMGB1 levels were the same in control and silica treated WT
mice, and because equal protein was loaded and the fact that the
protein concentration in the BALF of WT mice after silica challenge
approximately doubled, the overall amount of HMBG1 in the BALF (I.e.
amount per volume BALF) is actually increased, this observation was
the same for RAGE KO mice (B). (C) Compares HMGB1 levels after
treatment with silica in WT and RAGE KO. HMGB1 levels varied to a high
degree between samples, and there was no significant difference
between the two strains as determined by densitometry analysis.
doi:10.1371/journal.pone.0009604.g006
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PLoS ONE | www.plosone.org 9 March 2010 | Volume 5 | Issue 3 | e9604Figure 7. Lung mechanics after silica injury. Changes in lung mechanics were similar in WT and RAGE KO mice. Closed bars represent silica treatment and
open bars vehicle control. (A) While the airway resistance in silica treated WT mice was not significantly increased over control, the RAGE KO mice treated with
silica had asignificant increase. All other values (B–E) were significantly changed for both WT and RAGE KO; however there wereno other significant differences
between WT and RAGE KO. Data are means (6SEM) analyzed by 2-way ANOVA with a Bonferroni post-test. (n=5–6pergroup). * p,0.05 silica vs. control.
doi:10.1371/journal.pone.0009604.g007
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PLoS ONE | www.plosone.org 10 March 2010 | Volume 5 | Issue 3 | e9604Figure 8. Dose response to silica. (A) The high dose of silica resulted in a significantly higher increase in total cells/mL in the BALF of RAGE KO
mice compared to WT mice. (B) RAGE KO mice had more macrophages than WT at the high dose of silica. (C) Neutrophil levels were significantly
lower in RAGE KO mice compared to WT mice for all doses of silica. (D) Lymphocyte levels were different among the two strains at the two lower
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resemble what takes place in the asbestos model, since they are
both fibers/particles that persist in the lung. Furthermore, RAGE/
collagen IV interactions have previously been shown to be
important for epithelial cell spreading [38] and possibly wound
healing. Based on this we hypothesized that an increase of RAGE
ligands could lead to decreased re-epithelialization after injury and
furthermore that RAGE KO mice would get worse fibrosis since
they would have decreased ability to re-epithelialize. However,
while we found no difference in the absolute degree of fibrosis
between WT and RAGE KO mice treated with silica, histolog-
ically the RAGE KO mice had a more diffuse pattern of fibrosis
compared to the dense nodular fibrosis in the WT mice.
Pulmonary function studies also showed a trend of increased
airway resistance in the RAGE KO compared to WT after silica
injury. The RAGE/collagen IV interaction might explain why
RAGE expressing WT mice are able to restrict the spreading of
fibrosis more effectively than RAGE KO mice. The interaction
may function to control the cell spreading even during wound
healing, and hence the fibrosis develops as nodules with clearly
defined edges, whereas RAGE KO mice are not able to control
the spreading of epithelial cells and therefore develop a more
diffuse pattern of fibrosis. Another possibility could be that
macrophages phagocytozing silica particles subsequently migrate
towards each other in order to condense the silica particles and
limit the extent of fibrosis. It could be that RAGE KO
macrophages have a changed ability to perform this task.
TGF-b levels in BALF samples of silica treated RAGE KO mice
were significantly lower than in WT mice. This finding may
explain why the two strains get similar amount of fibrosis. As
previously mentioned RAGE KO mice get more fibrosis in an
asbestos model, while in a bleomycin model they are largely
protected [21,22]. If RAGE KO mice are actually more
susceptible to developing fibrosis when challenged i.t. with a
particular/fibrillar agent, but at the same time have less TGF-b,
then the overall amount of fibrosis may end up being the same.
A dose response study with 3 different amounts of silica showed
similar degrees of fibrosis, but some differences in inflammatory
cell population between RAGE KO and WT mice. Furthermore,
protein leakage into the lung was significantly higher in RAGE
KO mice than in WT mice, indicating that the integrity of the
alveolar wall is more fragile/susceptible to damage in RAGE KO
mice. Taken together this indicates that RAGE may be involved in
the inflammatory response and adherence of epithelial cells, but
not in the subsequent development of fibrosis after silica induced
lung damage. The RAGE KO mice used in this study are
constitutive global RAGE KO mice. It is possible that the
constitutive RAGE KO mice may have up- or down regulated
proteins as an adaptive response to the loss of pulmonary RAGE
expression. RAGE may also be involved in the regulation of other
proteins whose expression could be dramatically altered by the
knockout of RAGE. Notably, a recent study using inducible EC-
SOD KO mice showed that while constitutive EC-SOD KO mice
were viable and had a phenotype resembling WT mice, the
conditional EC-SOD KO mice died rapidly with symptoms
resembling acute lung injury after inducing the knockout of EC-
SDO [39]. Further studies will be necessary to study potential
differentially regulated proteins between WT and RAGE KO
mice. In addition, an inducible RAGE KO mouse strain may help
shed light on the inflammatory function of RAGE and its
involvement in lung pathology where this protein is so highly
expressed.
In summary, except for the altered histologic pattern of fibrosis,
there is no data to suggest that RAGE expression alters the degree
of fibrosis using a silica induced model of pulmonary fibrosis.
RAGE does appear to be a strong marker of epithelial cell injury
in that both a decrease in pulmonary protein levels of RAGE and
a decrease in RAGE mRNA levels are seen in response to fibrotic
injury. The markedly different responses of RAGE KO mice to
different models of pulmonary fibrosis suggest that RAGE does
play a role in the pathogenesis of pulmonary fibrosis, but its role
depends on the injury eliciting the fibrotic response. Further
investigation is necessary in order to fully understand the
mechanisms RAGE plays in pulmonary fibrosis and how to best
exploit RAGE biology to intervene in the fibrotic response.
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